+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Entry Inhibitor"

From
HIV Drugs Market Report 2025 - Product Thumbnail Image

HIV Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 164 Pages
  • Global
From
From
From
From
Diagnostics and Therapeutics for HIV: Global Markets - Product Thumbnail Image

Diagnostics and Therapeutics for HIV: Global Markets

  • Report
  • October 2023
  • 186 Pages
  • Global
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Entry inhibitors are a class of antiretroviral drugs used to treat HIV/AIDS. They work by blocking the virus from entering and infecting healthy cells. Entry inhibitors are used in combination with other antiretroviral drugs to reduce the amount of virus in the body and prevent the development of drug resistance. They are also used to reduce the risk of transmission of HIV from one person to another. Entry inhibitors are an important part of HIV/AIDS treatment, as they can help to reduce the amount of virus in the body and prevent the development of drug resistance. They are also used to reduce the risk of transmission of HIV from one person to another. The entry inhibitor market is highly competitive, with many companies offering different types of entry inhibitors. Some of the major companies in the market include Gilead Sciences, Merck, Bristol-Myers Squibb, and ViiV Healthcare. Show Less Read more